Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial
Vanita Noronha, Kumar Prabhash(Homi Bhabha National Institute), Tejpal Gupta(Tata Memorial Hospital), Aparna Manjrekar, Atanu Bhattacharjee, Arati Sanjay Bhelekar, Vijay Patil, Sarbani Ghosh Laskar(Tata Memorial Hospital), Vijayalakshmi Mathrudev, Vedang Murthy(Homi Bhabha National Institute), Pankaj Chaturvedi(Tata Memorial Hospital), Kamesh Maske, Amit Joshi(Dr. Rajendra Prasad Government Medical College), Nikhil Pande, Shripad Banavali(Tata Memorial Hospital), Vikram Gota, Shashikant Juvekar, Ashwini Budrukkar(Tata Memorial Hospital), Vikas Talreja, Sadhana Kannan(Homi Bhabha National Institute), Devendra Chaukar, Jaiprakash Agarwal(Tata Memorial Hospital), Shubhada Kane, Kavita Nawale, Anil D′Cruz(Apollo Hospitals), Prathamesh Pai(Tata Memorial Hospital), Dilip Harindran Vallathol, Arun Chandrasekharan
Cited by 340
Related Papers
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
|European Urology|2017|644
Toward the Cure of All Children With Cancer Through Collaborative Efforts: Pediatric Oncology As a Global Challenge
|Journal of Clinical Oncology|2015|459
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
|European Urology|2020|396
Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis
|European Journal of Nuclear Medicine and Molecular Imaging|2011|377